Glaucoma Trial, Recruiting NCT07310719 Sponsor: Lagos State Health Service Commission Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT07310719
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older.
  • You have recently been diagnosed with a type of glaucoma called Primary Open Angle Glaucoma (POAG) or a condition called Ocular Hypertension (OHT), where the pressure in your eye is higher than normal.
  • The pressure in your eye has been measured as higher than 21mmHg across three separate clinic visits.
  • Your glaucoma has been assessed as early or moderate stage based on eye scans and examinations (confirm with trial site for specific measurements).
  • You are willing to take part in the study and have given your written agreement to do so.

Who may not be able to join:

  • You have previously had any medical treatment, surgery, or laser procedure for glaucoma.
  • You have been diagnosed with a type of glaucoma that is present from birth (congenital glaucoma) or glaucoma caused by another condition (secondary glaucoma).
  • Your glaucoma has been assessed as advanced stage based on eye examination results (confirm with trial site for specific measurements).
  • You have a cloudy or scarred cornea (the clear front surface of your eye) that could affect eye pressure readings or the ability to examine your eye properly.
  • You have any cloudiness inside the eye, such as cataracts or bleeding in the eye, that prevents a proper examination of the back of the eye.
  • You have had previous eye surgery, such as cataract surgery or glaucoma surgery.
  • You have a history of an eye injury or inflammation inside the eye (uveitis).
  • You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Prof B. Adekoya, FWACS, MD, Lagos State University

Phone: +234 7061339223

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lagos State Health Service Commission
Registry
ClinicalTrials.gov
Start date
15 October 2025
Est. completion
1 September 2026

Where this trial is recruiting

Nigeria

Primary endpoints

Percentage intraocular pressure reduction from baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov